Log in
Enquire now
‌

US Patent 8030518 1,4 diamino bicyclic retigabine analogues as potassium channel modulators

Patent 8030518 was granted and assigned to Valeant Pharmaceuticals on October, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Valeant Pharmaceuticals
Valeant Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8030518
Date of Patent
October 4, 2011
Patent Application Number
11946822
Date Filed
November 28, 2007
Patent Primary Examiner
‌
Shailendra Kumar
Patent abstract

This invention is directed to compounds of formula I,

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8030518 1,4 diamino bicyclic retigabine analogues as potassium channel modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.